The Long-Term Omalizumab Therapy in Children With Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry
Pediatric pharmacology
doi 10.15690/pf.v15i2.1877
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2018
Authors
Publisher
Paediatrician Publishers LLC